The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Open accessAbstract
Proton pump inhibitors (PPIs) were clinically introduced more than 25 years ago and have since proven to be invaluable, safe, and effective agents for the management of a variety of acid-related disorders. Although all members in this class act in a similar fashion, inhibiting active parietal cell acid secretion, there are slight differences among PPIs relating to their pharmacokinetic properties, metabolism, and Food and Drug Administration (FDA)-approved clinical indications. Nevertheless, each is effective in managing gastroesophageal reflux disease and uncomplicated or complicated peptic ulcer disease. Despite their overall efficacy, PPIs do have some limitations related to their short plasma half-lives and requirement for meal-associated dosing, which can lead to breakthrough symptoms in some individuals, especially at night. Longer-acting PPIs and technology to prolong conventional PPI activity have been developed to specifically address these limitations and may improve clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Medical treatments in the short term management of reflux oesophagitis
Moayyedi, P., Santana, J., Khan, M., Preston, C., & Donnellan, C. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003244.pub3 · Cited by 239
RetractedMedical treatments in the short term management of reflux oesophagitis
Moayyedi, P., Santana, J., Khan, M., Preston, C., & Donnellan, C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003244.pub2 · Cited by 172
RetractedManagement of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,266
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
El-Serag, H. B., Sweet, S., Winchester, C. C., & Dent, J. (2014) · Gut · doi:10.1136/gutjnl-2012-304269 · Cited by 1,927
Epidemiology of gastro-oesophageal reflux disease: a systematic review
Dent, J. (2005) · Gut · doi:10.1136/gut.2004.051821 · Cited by 1,887
Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease
Katz, P. O., Gerson, L. B., & Vela, M. F. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.444 · Cited by 1,767
Gabriel, S. E., Jaakkimainen, L., & Bombardier, C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-10-787 · Cited by 1,237
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
Yang, Y.-X., Lewis, J. D., Epstein, S., & Metz, D. C. (2006) · JAMA · doi:10.1001/jama.296.24.2947 · Cited by 1,214
Barkun, A. N., Bardou, M., Kuipers, E. J., Sung, J., Hunt, R. H., Martel, M., Sinclair, P., & for the International Consensus Upper Gastrointestinal Bleeding Conference Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00009 · Cited by 1,163
Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease
DeVault, K. R., & Castell, D. O. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41217.x · Cited by 1,130
Chiba, N., De Gara, C., Wilkinson, J., & Hunt, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9178669 · Cited by 857
Writing Committee Members, Bhatt, D. L., Scheiman, J., Abraham, N. S., Antman, E. M., Chan, F. K. L., Furberg, C. D., Johnson, D. A., Mahaffey, K. W., & Quigley, E. M. (2008) · Circulation · doi:10.1161/circulationaha.108.191087 · Cited by 843
Management of Patients With Ulcer Bleeding
Laine, L., & Jensen, D. M. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.480 · Cited by 807
Guidelines for Prevention of NSAID-Related Ulcer Complications
and the Practice Parameters Committee of the American College of Gastroenterology, Lanza, F. L., Chan, F. K. L., & Quigley, E. M. M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.115 · Cited by 790
Kuipers, E. J., Lundell, L., Klinkenberg-Knol, E. C., Havu, N., Festen, H. P. M., Liedman, B., Lamers, C. B. H. W., Jansen, J. B. M. J., Dalenbäck, J., Snel, P., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604183341603 · Cited by 769
Laine, L., & Peterson, W. L. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409153311107 · Cited by 719
Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis
Kwok, C. S., Arthur, A. K., Anibueze, C. I., Singh, S., Cavallazzi, R., & Loke, Y. K. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.108 · Cited by 581
Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
Wallace, J. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041264 · Cited by 569
Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding
Barkun, A., Bardou, M., Marshall, J. K., & for the Nonvariceal Upper GI Bleeding Consensus Conference Group* (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00012 · Cited by 544
A Comparison of Five Maintenance Therapies for Reflux Esophagitis
Vigneri, S., Termini, R., Leandro, G., Badalamenti, S., Pantalena, M., Savarino, V., Di Mario, F., Battaglia, G., Mela, G. S., Pilotto, A., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510263331703 · Cited by 542
Sigterman, K. E., van Pinxteren, B., Bonis, P. A., Lau, J., & Numans, M. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002095.pub5 · Cited by 507
Bavishi, C., & DuPont, H. L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04874.x · Cited by 480
Kahrilas, P. J., Shaheen, N. J., & Vaezi, M. F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.044 · Cited by 431
Review article: the clinical pharmacology of proton pump inhibitors
SACHS, G., SHIN, J. M., & HOWDEN, C. W. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02943.x · Cited by 407
Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next?
FASS, R., SHAPIRO, M., DEKEL, R., & SEWELL, J. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02531.x · Cited by 394
Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis
Eom, C.-S., Jeon, C. Y., Lim, J.-W., Cho, E.-G., Park, S. M., & Lee, K.-S. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.092129 · Cited by 393
Laine, L., & McQuaid, K. R. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.016 · Cited by 387
Bhatt, D. L., Scheiman, J., Abraham, N. S., Antman, E. M., Chan, F. K. L., Furberg, C. D., Johnson, D. A., Mahaffey, K. W., Quigley, E. M., Harrington, R. A., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.002 · Cited by 385
Talley, Meineche‐Schmidt, Paré, Duckworth, Räisänen, Pap, Kordecki, & Schmid (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00410.x · Cited by 381
Wolfe, M. M., & Sachs, G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70004-7 · Cited by 354
Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis
Lo, W., & Chan, W. W. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.011 · Cited by 353
Furuta, T., Ohashi, K., Kamata, T., Takashima, M., Kosuge, K., Kawasaki, T., Hanai, H., Kubota, T., Ishizaki, T., & Kaneko, E. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-12-199812150-00006 · Cited by 335
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
Shi, S., & Klotz, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0538-y · Cited by 314
Ito, T., & Jensen, R. T. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0141-0 · Cited by 309
Sreedharan, A., Martin, J., Leontiadis, G. I., Dorward, S., Howden, C. W., Forman, D., & Moayyedi, P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005415.pub3 · Cited by 304
Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia
Sarkar, M., Hennessy, S., & Yang, Y.-X. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-6-200809160-00005 · Cited by 301
Scheiman, J. M., Yeomans, N. D., Talley, N. J., Vakil, N., Chan, F. K. L., Tulassay, Z., Rainoldi, J. L., Szczepanski, L., Ung, K.-A., Kleczkowski, D., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00499.x · Cited by 298
Ngamruengphong, S., Leontiadis, G. I., Radhi, S., Dentino, A., & Nugent, K. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.113 · Cited by 281
Taha, A. S., McCloskey, C., Prasad, R., & Bezlyak, V. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61246-0 · Cited by 228
Fitton, A., & Wiseman, L. (1996) · Drugs · doi:10.2165/00003495-199651030-00012 · Cited by 205
Filion, K. B., Chateau, D., Targownik, L. E., Gershon, A., Durand, M., Tamim, H., Teare, G. F., Ravani, P., Ernst, P., Dormuth, C. R., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304738 · Cited by 183
Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors
Kaye, J. A., & Jick, H. (2008) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.8.951 · Cited by 182
Abraham, N. S., Hlatky, M. A., Antman, E. M., Bhatt, D. L., Bjorkman, D. J., Clark, C. B., Furberg, C. D., Johnson, D. A., Kahi, C. J., Laine, L., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.445 · Cited by 179
Optimum duration of regimens for Helicobacter pylori eradication
Yuan, Y., Ford, A. C., Khan, K. J., Gisbert, J. P., Forman, D., Leontiadis, G. I., Tse, F., Calvet, X., Fallone, C., Fischbach, L., et al. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008337.pub2 · Cited by 171
Welage, L. S., & Berardi, R. R. (2000) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31036-1 · Cited by 149
Role of endoscopy in the management of GERD
Lichtenstein, D. R., Cash, B. D., Davila, R., Baron, T. H., Adler, D. G., Anderson, M. A., Dominitz, J. A., Gan, S. I., Harrison, M. E., Ikenberry, S. O., et al. (2007) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2007.05.027 · Cited by 140
Koch, M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440190069008 · Cited by 131
Marshall, B. J. (1994) · PubMed · Cited by 123
Changing Patterns of Helicobacter pylori Gastritis in Long‐Standing Acid Suppression
Moayyedi, P., Wason, C., Peacock, R., Walan, A., Bardhan, K. D., Axon, A. T. R., & Dixon, M. F. (2000) · Helicobacter · doi:10.1046/j.1523-5378.2000.00032.x · Cited by 121
Pace, F., Tonini, M., Pallotta, S., Molteni, P., & Porro, G. B. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03381.x · Cited by 112
Peura, D. A., Kovacs, T. O. G., Metz, D. C., Siepman, N. Y., Pilmer, B. L., & Talley, N. J. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.01.008 · Cited by 111
Self-citationPrakash, A., & Faulds, D. M. (1998) · Drugs · doi:10.2165/00003495-199855020-00009 · Cited by 108
Pharmacokinetic Considerations in the Eradication of Helicobacter Pylori
Klotz, U. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038030-00004 · Cited by 105
Fass, R., Johnson, D. A., Orr, W. C., Han, C., Mody, R., Stern, K., Pilmer, B. L., & Perez, C. M. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.458 · Cited by 103
Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high
Metz, D. C., Pisegna, J. R., Fishbeyn, V. A., Benya, R. V., Feigenbaum, K. M., Koviack, P. D., & Jensen, R. T. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91170-9 · Cited by 97
Review article: the pharmacology of rabeprazole
Williams, & Pounder (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00019.x · Cited by 89
Lundell, L. R., Havu, N., Miettinen, P. S., Myrvold, H. E., Wallin, L., Julkunen, R. J. K., Levander, K., Hatlebakk, J. G., Liedman, B., Lamm, M., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02792.x · Cited by 88
Optimizing acid suppression for treatment of acid-related diseases
Hunt, R. H., Cederberg, C., Dent, J., Halter, F., Howden, C. W., Marks, I. N. S., Rune, S. J., & Walt, R. P. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02214870 · Cited by 87
On-Demand Therapy for Gastroesophageal Reflux Disease
Metz, D. C., Inadomi, J. M., Howden, C. W., van Zanten, S. J. V., & Bytzer, P. M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00998.x · Cited by 78
Economic Costs of Functional Dyspepsia
Nyrén, O., Lindberg, G., Lindström, E., Marké, L.-Å., & Seensalu, R. (1992) · PharmacoEconomics · doi:10.2165/00019053-199201050-00003 · Cited by 77
Hunt, R. H., Armstrong, D., James, C., Chowdhury, S. K., Yuan, Y., Fiorentini, P., Taccoen, A., & Cohen, P. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41956.x · Cited by 75
Treatment patterns and symptom control in patients with GERD: US community-based survey
Chey, W. D., Mody, R., Wu, E. Q., Chen, L., Kothari, S., Persson, B., Beaulieu, N., & Lü, M. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903035745 · Cited by 71
Chey, W. D., Inadomi, J. M., Booher, A. M., Sharma, V. K., Fendrick, A. M., & Howden, C. W. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41364.x · Cited by 67
Eriksson, S., Långström, G., Rikner, L., Carlsson, R., & Næsdal, J. (1995) · PubMed · Cited by 64
Poynard, T., Lemaire, M., & Agostini, H. (1995) · PubMed · Cited by 63
Chey, W. D., Mody, R., & Izat, E. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1209-2 · Cited by 63
Zollinger-Ellison Syndrome: Advances in Treatment of Gastric Hypersecretion and the Gastrinoma
Jensen, R. T. (1994) · JAMA · doi:10.1001/jama.271.18.1429 · Cited by 62
Fass, R., Inadomi, J. M., Han, C., Mody, R., O’Neil, J., & Pérez, M. C. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.11.021 · Cited by 59
Nocturnal acid breakthrough - approach to management.
Tutuian, R. I., & Castell, D. O. (2004) · PubMed · Cited by 43
Tutuian, R. I., Katz, P. O., & Castell, D. O. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200405000-00001 · Cited by 40
Galmiche, J., Sacher‐Huvelin, S., Varannes, S. B. D., Vavasseur, F., Taccoen, A., Fiorentini, P., & Homerin, M. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02381.x · Cited by 39
pH, healing rate and symptom relief in acid-related diseases.
Huang, J. Q., & Hunt, R. H. (1996) · PubMed Central · Cited by 38
Seguridad de la utilización de los inhibidores de la bomba de protones
Esplugues, J. V., Martí‐Cabrera, M., & Ponce, J. (2006) · Medicina Clínica · doi:10.1157/13095825 · Cited by 33
Jensen, R. T. (1994) · JAMA · doi:10.1001/jama.1994.03510420061035 · Cited by 31
The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage
Tuskey, A. G., & Peura, D. A. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4178 · Cited by 30
Self-citationLong-term proton pump inhibitor administration, H pylori and gastric cancer: lessons from the gerbil
Fox, J. G., & Kuipers, E. J. (2011) · Gut · doi:10.1136/gut.2010.229286 · Cited by 25
Optimizing the pharmacology of acid control in acid-related disorders.
Cw, H. (1997) · PubMed · Cited by 15
Acid-related disorders and use of antisecretory medication.
Lassen, A. T. (2007) · PubMed · Cited by 15
Kushner, P. R., & Peura, D. A. (2011) · Advances in Therapy · doi:10.1007/s12325-011-0013-5 · Cited by 12
Self-citationLanza, F., Goff, J., Silvers, D. S., Winters, J., Jhala, N., Jennings, D. E., & Rose, P. A. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018868713520 · Cited by 9
Cited by
Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment Options
Kuna, L., Jakab, J., Smolic, R., Raguz-Lucic, N., Vcev, A., & Smolic, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020179 · Cited by 349
Diagnosis and Treatment of Peptic Ulcer Disease
Kavitt, R. T., Lipowska, A. M., Anyane-Yeboa, A., & Gralnek, I. M. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.12.009 · Cited by 313
Chirality of New Drug Approvals (2013–2022): Trends and Perspectives
McVicker, R. U., & O’Boyle, N. M. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02239 · Cited by 255
Miao, J., & Herrmann, S. M. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad109 · Cited by 31
“PPI is mainly used for treatment of acid-related disorders, such as peptic ulcer disease, GERD, erosive esophagitis, and Barrett’s esophagus [29].”
BackgroundCantarelli, L., Gutiérrez Nicolás, F., García Gil, S., Morales Barrios, J. A., Oramas Rodriguez, J., & Nazco Casariego, G. J. (2024) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000494 · Cited by 4
Metadata
- Authors
- Strand, D. S., Kim, D., & Peura, D. A.
- Venue
- Gut and Liver
- Published
- 2017-01-15
- Volume
- 11
- Issue
- 1
- Pages
- 27-37
- ISSN
- 1976-2283 (ISSN-L)
- 2005-1212
- OpenAlex
- W2550831966
- Cited by
- 671
- References
- 80
- FWCI
- 28.78
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.